A study comparing recovery outcomes between enhanced recovery care and conventional care after keyhole gynaecological surgery

A randomized controlled trial comparing outcomes in patients undergoing laparoscopic benign gynaecological procedure with enhanced recovery after surgery (ERAS) care versus conventional care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN39151607

Enrollment

Registered

2025-11-15

Start date

2023-12-01

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative care in minimally invasive gynaecological surgery Surgery

Interventions

A randomized controlled trial comparing outcomes in patients undergoing laparoscopic benign gynaecological procedure with enhanced recovery after surgery (ERAS) care versus conventional care. This is

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Women who are scheduled for elective laparoscopic surgery with benign gynaecological indication in the form of procedure salpingectomy, salpingo-oopherectomy, ovarian cystectomy, myomectomy or hysterectomy with or without bilateral salpingo-oophorectomy) 2. American Society of Anesthesiologist (ASA) classification I-II 3. Aged 18-65 years 4. Distance between patient’s home and hospital less than 50 km radius

Exclusion criteria

Exclusion criteria: 1. Malignancy 2. Pregnancy 3. Logistic problem and residence out of 50 km radius 4. Intellectual disability, impaired cognition 5. Allergic to drug in study protocol 6. History of anesthesia complication 7. Sleep apnea 8. Poorly controlled asthma and chronic obstructive pulmonary disease 9. On therapeutic anticoagulation 10. History of arrhythmia, congestive heart failure, pacemaker or hypertension require more than three medications 11. Type 1 Diabetes mellitus, poorly control Type 2 Diabetes mellitus where HbA1c >7.9% 12. Significant underlying kidney disease (eGFR <30 mL/min/1.73m2) 13. Liver cirrhosis 14. Daily alcohol consumption more than 2 drinks

Design outcomes

Primary

Measure	Time frame
Postoperative length of stay, from completion of surgery to time documented meet the fit-for-discharge criteria	—

Secondary

Measure	Time frame
1. Postoperative pain measured using numerical rating scale at 6 hours and 12 hours post operation 2. Readmission rate within 30 days, follow up subject until 30 days post operation 3. Postoperative complications defined according to Clavien-Dindo classification from post operation till 1 month post operation	—

Countries

Malaysia

Contacts

Public ContactChien Huey Ng

chien@live.com.my+60 (0)108978511

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026